BNP Paribas Financial Markets’s TriSalus Life Sciences TLSI Stock Holding History

BNP Paribas Financial Markets’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.8K	Buy	7,199 +1,323	+23%	+$5.26K	﹤0.01%	5098
2026 Q1	$23.5K	Sell	5,876 -509	-8%	-$2.49K	﹤0.01%	5041
2025 Q4	$44.6K	Buy	6,385 +1,611	+34%	+$9.02K	﹤0.01%	4739
2025 Q3	$22.2K	Buy	4,774 +1,759	+58%	+$8.24K	﹤0.01%	4889
2025 Q2	$16.4K	Buy	+3,015	New	+$16.2K	﹤0.01%	4686

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BNP Paribas Financial Markets's TLSI Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its TriSalus Life Sciences (TLSI) stake by 23% in Q2 2026, buying an estimated $5.26K and bringing the position to 7,199 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5098.

BNP Paribas Financial Markets first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. The position peaked at $44.6K in Q4 2025. 73 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

BNP Paribas Financial Markets held 7,199 shares of TriSalus Life Sciences worth $32.8K as of Q2 2026.
BNP Paribas Financial Markets bought 1,323 TriSalus Life Sciences shares in Q2 2026, an estimated $5.26K.
TriSalus Life Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5098 holding.
BNP Paribas Financial Markets first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
BNP Paribas Financial Markets's TriSalus Life Sciences position peaked at $44.6K in Q4 2025.
73 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.